icatibant
Generic: icatibant
Labeler: fresenius kabi usa, llcDrug Facts
Product Profile
Brand Name
icatibant
Generic Name
icatibant
Labeler
fresenius kabi usa, llc
Dosage Form
INJECTION, SOLUTION
Routes
Active Ingredients
icatibant acetate 10 mg/mL
Manufacturer
Identifiers & Regulatory
Product NDC
63323-574
Product ID
63323-574_d1c9afa7-c4ac-4739-85f1-2ae82440210c
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA208317
Listing Expiration
2026-12-31
Marketing Start
2020-11-15
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
63323574
Hyphenated Format
63323-574
Supplemental Identifiers
RxCUI
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
icatibant (source: ndc)
Generic Name
icatibant (source: ndc)
Application Number
ANDA208317 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 10 mg/mL
Packaging
- 1 SYRINGE in 1 CARTON (63323-574-86) / 3 mL in 1 SYRINGE (63323-574-01)
- 3 CARTON in 1 BOX (63323-574-93) / 1 SYRINGE in 1 CARTON / 3 mL in 1 SYRINGE
Packages (2)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["SUBCUTANEOUS"], "spl_id": "d1c9afa7-c4ac-4739-85f1-2ae82440210c", "openfda": {"unii": ["325O8467XK"], "rxcui": ["1148141"], "spl_set_id": ["52c12c15-c00b-4efc-952d-1425c907706a"], "manufacturer_name": ["Fresenius Kabi USA, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 SYRINGE in 1 CARTON (63323-574-86) / 3 mL in 1 SYRINGE (63323-574-01)", "package_ndc": "63323-574-86", "marketing_start_date": "20201115"}, {"sample": false, "description": "3 CARTON in 1 BOX (63323-574-93) / 1 SYRINGE in 1 CARTON / 3 mL in 1 SYRINGE", "package_ndc": "63323-574-93", "marketing_start_date": "20201115"}], "brand_name": "Icatibant", "product_id": "63323-574_d1c9afa7-c4ac-4739-85f1-2ae82440210c", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Bradykinin B2 Receptor Antagonist [EPC]", "Bradykinin B2 Receptor Antagonists [MoA]"], "product_ndc": "63323-574", "generic_name": "Icatibant", "labeler_name": "Fresenius Kabi USA, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Icatibant", "active_ingredients": [{"name": "ICATIBANT ACETATE", "strength": "10 mg/mL"}], "application_number": "ANDA208317", "marketing_category": "ANDA", "marketing_start_date": "20201115", "listing_expiration_date": "20261231"}